The papular-purpuric gloves and socks syndrome (PPGSS) was first described in 1990. This syndrome is characterized by fever, acral pruritus, edema, petechiae, and oral erosions. Subsequently, parvovirus B19 has been implicated, in most cases, as the causative agent of this syndrome. To date, with two exceptions, all published cases of PPGSS have been from Europe and the Middle East and have been mainly reported in the dermatology literature. Herein, we report what we believe to be only the second case of documented parvovirus B19 -associated PPGSS occurring in the United States. The patient presented with the typical clinical syndrome, and the diagnosis of acute parvovirus B19 infection was documented by serial serologies that demonstrated development of IgM antibody to virus during the acute phase of infection and seroconversion to IgG antibody in the convalescent period. We then review the existing literature on this unusual syndrome and its association with parvovirus B19.
In 1990, Harms et al. [1] reported five cases of an acute parvovirus B19 -associated PPGSS occurring in the United States. Similar to prior reports, through serological analysis, self-limited dermatosis that initially presented as pruritic and painful edema and erythema localized to the distal upper and we were able to implicate parvovirus B19 as the causative agent. We then review the existing data on this unusual synlower extremities in a gloves and socks distribution. This syndrome was further characterized by the subsequent appearance drome, with particular attention paid to the data supporting parvovirus B19 as the primary causative agent. of acral petechiae and oral ulcerations followed by rapid clearing of all mucocutaneous changes. No obvious infectious or noninfectious etiologic agent was identified. The dermatosis, Case Report which has since been well described in the dermatology literature, is termed the papular-purpuric gloves and socks syndrome A 20-year-old woman presented in April 1997 to Yale -New (PPGSS).
Haven Hospital (New Haven, CT) for evaluation of acute-onset In 1991, Bagot and Revuz [2] , in a letter to the editor, pain and swelling of her hands, feet, and oropharynx. Four described a patient who presented with an identical syndrome days before admission, a cutaneous eruption appeared on the in association with acute infection with parvovirus B19, the dorsum of both hands and feet, which subsequently progressed latter documented by acute seroconversion by means of serial to involve the palmar surfaces. During this time, she also noted serologies for IgM antibody. Subsequently, Harms et al. [3] increasing pruritus of her hands and feet, which was not reagreed that an association between PPGSS and parvovirus B19 lieved by dipheniramine, prescribed 2 days before by her priwas apparent in the patient described by Bagot and Revuz; mary care physician whom she had seen because of these symphowever, they could not adequately prove that association in toms. One day before admission, she noted swelling of her their patients. They were only able to identify IgG antibody to lower lip followed by the onset of oropharyngeal pain and parvovirus B19 in a single, preserved, convalescent-phase seodynophagia, which ultimately precluded oral intake and rum specimen from one of their previously described patients.
prompted presentation to the emergency department and hospiMore recently, Halasz et al. [4] reported the first case of talization. parvovirus B19 -associated PPGSS occurring in the United At the time of evaluation in the emergency department, with States. Herein, we report only the second case of documented the exception of arthralgias of the knees and ankles, the patient denied any associated systemic or localizing symptoms, including fever, chills, headache, neck stiffness, nausea, vomiting, diarrhea, abdominal pain, dysuria, or vaginal discharge. She
On the day of admission, the patient was seen by both the infectious disease and dermatology consult services. A broad differential diagnosis was initially generated. However, on the basis of her clinical presentation, the most likely diagnosis entertained was PPGSS. A variety of blood analyses were recommended, samples for many of which were sent to our laboratory as noted. A skin biopsy of the petechial lesions was entertained but not thought likely to contribute to making a specific diagnosis.
Forty-eight hours into the hospitalization, the patient continued to be ill, and increasing mucocutaneous swelling and pain were noted. She became febrile (temperature to 38.6ЊC), and even though her hemoglobin level, hematocrit, and platelet count remained normal, her WBC count had declined from 5,600/mm 3 at the time of admission to 2,200/mm 3 with 16% Although the diagnosis remained unclear, a decision was made included moist mucous membranes, palatal ulcerations, and erythema. A whitish plaque also coated her tongue.
to administer intravenous steroids (methylprednisolone, 40 mg every 8 hours) in an attempt to alleviate primarily the oropharygeal pain and swelling that the patient was experiencing and, as a result, improve her oral intake. Within 24 hours, the pahood vaccines, including measles-mumps-rubella vaccine, and tient's lip swelling, mouth pain, and acral pruritus markedly immunity was documented prenatally. She denied recent travel, decreased, and her hematologic abnormalities resolved. On day insect bites, tick exposures, or outside activities such as garden-9 of her illness the patient was discharged to home, at which ing or walking through wooded areas. She had one indoor adult time samples for repeated serologies for parvovirus B19 were cat and two children, the youngest of whom was an 8-monthobtained. old boy who attended day care and had developed, 2 weeks Following discharge, results of parvovirus B19 serologies before her illness, a fever and a ''slapped cheeks'' facial rash became available. IgM but not IgG antibody to parvovirus B19 that was diagnosed clinically by his pediatrician as fifth disease.
was detected in the serum sample drawn on day 9 of the paWe were subsequently notified by our hospital virology laboratient's illness. The blood specimen obtained on day 2 of her tory of a documented outbreak of parvovirus infection that had illness was negative for both IgM and IgG antibodies to parvooccurred in the community at the time of this patient's illness. virus B19. All other diagnostic tests, including that for antibody Physical examination was notable for a temperature of to HIV, were negative. Testing of convalescent-phase serum 37.6ЊC. Examination of the oral mucosa revealed moist, edemasamples, obtained 9 months after the illness when the patient tous lips and a scattering of 2-to 3-mm vesiculopustular lesions returned for follow-up, revealed IgG but not IgM antibody to over the hard and soft palates (figure 1). Her tongue was incidentally noted to be coated with a thick white plaque. A petechial eruption was distributed over edematous, tender, distal extremities in a gloves and socks distribution, with a welldefined demarcation at the wrists and ankles (figure 2). The remainder of her physical examination, including a pelvic evaluation, was unremarkable.
Results of initial laboratory tests, including serum chemistry analysis, urinalysis, and a complete blood cell count, were normal. The erythrocyte sedimentation rate was 41 mm/h. Multiple blood culture specimens, a viral throat culture specimen, and a cervical specimen were sent to our laboratory, as were specimens for determination of an antistreptolysin ( ASLO ) titer, monospot test, and serologies for coxsackievirus, cytomegalovirus, hepatitis B and C viruses, and HIV type 1. Samples for serology for both IgM and IgG antibodies specific to parvovirus B19 had been sent to our laboratory by the patient's assayed for IgM antibody to parvovirus B19 were positive within the first 23 days following the onset of skin manifestations. In 11 of these cases, seroconversion from IgM to IgG Discussion antibody was documented. IgG antibody was subsequently detected no earlier than day 9 and persisted for ú6 months after Parvovirus B19 is the etiologic agent of the common childhood exanthem erythema infectiosum (EI), also known as fifth the illness [8] . In three cases, diagnosis was further confirmed by plasma viremia in acute-phase serum samples by means of disease. Less frequently, acute parvovirus B19 infection may manifest as an atypical dermatosis. Unusual cutaneous manifes-PCR analysis for DNA [8] . Other etiologic agents implicated as possible causes of tations described to date include a vesiculopustular skin eruption [5] , generalized erythematous lesions, an erythematomacu-PPGSS include cytomegalovirus, coxsackie B6 virus, and measles virus. Carrascosa [9] suggested that cytomegalovirus could lopapular or maculopapular rash [6] , erythema multiforme ampullosum [7] , and PPGSS [2, 4, 6, 8 -16] .
be the causative agent in one case ( (table 1) . However, these antibody titers were only a twofold dilution apart. A fourfold difference is usually adenopathy (16%), and arthralgias (12%).
The distinctive manifestations of this syndrome are a rapidly considered significant. Serology for parvovirus B19 was negative in both acute-and convalescent-phase serum samples from progressive painful and highly pruritic, symmetric swelling and erythema of the distal hands and feet. Confluent papularthis patient, as was PCR analysis of acute-phase serum. Finally, measles virus was implicated as the causative agent purpuric lesions then develop that involve the dorsal and palmar surfaces of the distal extremities, with sharp margins at the of PPGSS in an additional case when positive titers of IgM and IgG antibodies were noted (table 1) [11]. However, oral wrists and ankles. Subsequently, most patients develop a polymorphous enanthem involving the hard and soft palates, buccal mucosal involvement did not manifest in this patient. Therefore, this case may not, in fact, truly be PPGSS. In addition, mucosa, and lips. Several oropharyngeal changes have been described, the most common being diffuse erythema and swellin this last case, the investigators stated that serology for parvovirus was not available in their laboratory at the time of the ing of the lips, accompanied by vesicles, shallow ulcerations, and/or petechiae localized to one or both palates. These oral case. In our case, infections with each of the above-mentioned lesions are quite painful, are often pruritic, and have been described in over one-half of the cases reported to date.
viruses, as well as HIV, were considered at the time of the initial evaluation. A diagnosis of acute parvovirus B19 infecThe entire syndrome generally clears spontaneously within 1 to 2 weeks. Unlike our case, patients are usually able to tion was ultimately made on the basis of the presence of IgM antibody in serum samples assayed at two different times durmaintain adequate oral intake and require only symptomatic treatment for pain and pruritus. Three patients have been noted ing the patient's illness and was confirmed by sequential assays for IgG antibody to virus that employed acute-and convalesto have desquamation of the hands and feet as the syndrome resolved [8] .
cent-phase serum samples. Although PCR analysis for DNA can provide further confirmation of parvovirus B19 infection, Laboratory findings for patients with PPGSS are variable. The most common hematologic manifestations described have it is not clinically indicated for a healthy host. A third-generation EIA (Biotrin, Dublin, and Tri-Delta Diagbeen mild leukopenia, transient neutropenia, and one episode of eosinophilia [1, 4, 8] . The RBC indices and platelet counts nostics, Cedar Knolls, NJ) was used by our laboratory to detect IgM antibodies (class-capture sandwich EIA) and IgG antibodappear to remain normal. Other laboratory abnormalities have included mild elevations of transaminase levels and erythrocyte ies (sandwich EIA) to parvovirus B19. False positivity for IgM antibodies is always a concern. We are confident, however, sedimentation rates. No abnormalities in renal function have been reported to date.
that the results for this patient are accurate. First, results of IgM and IgG serologies evolved in a pattern coincident with On the basis of our experience and more recently published data, parvovirus B19 appears to be associated with most cases her clinical illness, which is characteristic of acute infection. Second, her illness occurred in the midst of a large epidemic of of PPGSS, as outlined in table 1. Parvovirus B19 has previously been implicated as the etiologic agent of PPGSS in 14 cases parvovirus B19 infection in the community. Finally, parvovirus / 9c51$$jy39 06-16-98 07:58:05 cida UC: CID 1 Cytomegalovirus Serology for IgM (A) [10] 5 Parvovirus B19 (1), parvovirus B19 (2), Serology for IgM (A, C) and PCR analysis (A, C; 1); serologies coxsackie B6 virus (3), none (4), for IgM (A, C) and IgG (C) and PCR analysis (A, C; 2); CF parvovirus B19 (5) assay , activity is common in April in Connecticut; in contrast, enteroThere was, however, IgG antibody to parvovirus already present in their specimens, which likely implies that the viremia virus infections in April are extremely rare.
Previously, it has been noted that parvovirus B19 infection had resolved (table 1) . Limited pathological data exist to help further delineate the manifests as a biphasic illness, characterized by a viremic phase that subsequently is followed by the host's development of an pathogenesis of PPGSS. Only a handful of patients have undergone skin biopsies, and, unfortunately, results of detailed viroimmunologic response to virus. As described by Anderson et al. [17] , when healthy volunteers were inoculated intranasally logical and immunologic studies on plasma specimens obtained from these same patients are lacking. Skin biopsies were perwith parvovirus B19, viral DNA was detected in the blood 6 days following infection. The previously seronegative healthy formed on three patients with PPGSS described by Aractingi et al. [12] . By means of histological analysis, they found predonors developed a mild illness manifested as pyrexia, malaise, myalgias, and generalized pruritus. Clearance of viremia was dominantly a CD3 / /CD30 / lymphocytic, perivascular infiltrate of the papillary dermis that was associated with extravasation correlated with the development of IgM antibodies by days 10 to 13 and of IgG antibodies that appeared following day 13.
of RBCs in the dermis. No evidence or changes diagnostic of a vasculitis were noted. However, by means of immunofluoIgM antibody levels began to fall after the second month of illness, whereas IgG antibody levels persisted indefinitely.
rescence with use of antibodies to parvovirus B19, intense labeling revealed the presence of virus in the endothelial cells It is interesting that there appear to be differences in the timing of antibody responses in relation to the clinical synof the dermal vessel walls. Virus was also noted in the epithelial cells of the sweat glands and ducts and in the epidermis. PCR dromes of EI and PPGSS. In patients with EI, typical symptoms usually develop following the clearance of viremia, in the setanalysis of skin biopsy specimens from all three patients further confirmed the presence of parvovirus B19 DNA in these leting of rising titers of IgM and IgG antibodies to virus. By the time the facial rash characteristic of EI develops, virus is ususions. In another study [13] , direct immunofluorescence of skin biopsy specimens obtained from patients with PPGSS revealed ally no longer detectable in the blood, and IgM and IgG antibodies are present [8, 12] . deposition of IgM antibody and C3 in the walls of papillary dermal vessels in a granular pattern, thus suggesting a vascular By contrast, in patients with PPGSS, on the basis of limited data that exist, it would appear that the mucocutaneous lesions reaction to an antigenic stimulus. The different dermatologic manifestations noted in patients develop during the period of viremia, following which antibodies appear. Several patients, including ours, did not have IgM with EI vs. those with parvovirus B19 -associated PPGSS perhaps reflect differences in the host's cellular and/or humoral antibodies at the time of their initial presentation with rash and pruritus. In addition, PCR analysis of serum from a limited immune response to one or more viral antigens. However, at this point, on the basis of results of limited detailed blood and number of these patients revealed circulating viral DNA [8, 12] . In contrast Borradori et al. [14] reported a case in which skin analyses that have been carried out for patients with either syndrome, it is difficult to speculate further regarding the prethey failed to detect viral DNA in serum by PCR analysis.
/ 9c51$$jy39
06-16-98 07:58:05 cida UC: CID cise nature of the host-virus interactions that occur in these two to characterizing both the kinetics of viremia and the host's immunologic response to the virus. Correlating these results illnesses. It is possible, although supporting data are currently lacking, that differences in host HLA type, preexisting immuwith findings of histological analysis of skin biopsy specimens could further enhance our understanding of the pathological nologic milieu, and/or level of viral inoculum may contribute to the variant clinical presentations seen with these two dermabasis of this disease. toses.
